AurorA debuts to back early-stage European biotechs

By Stephen Hansen, Associate Editor | Feb 12, 2020 | 10:54 PM GMT
Editor's note: Updated on Feb 13, 2020 at 9:53 PM GMT

A new Europe-focused investment vehicle has launched with €10 million in backing from two Italian biopharmas.

AurorA Science will be managed by

Read the full 213 word article

How to gain access

Continue reading with a
two-week free trial.